GSK2190915A - Bioavailability Study

Conditions

• Asthma

Interventions

• DRUG: GSK2190915 Solution.
• DRUG: GSK2190915 Granule Capsule (A)
• DRUG: GSK2190915 Semi-solid Lipid Capsule (B)
• DRUG: GSK2190915 Liquid Lipid Capsule (C)
• DRUG: GSK2190915 Milled Tablet
• DRUG: GSK2190915 Micronised Tablet

Sponsor

GlaxoSmithKline